PRESS RELEASE published on 04/15/2025 at 09:25, 9 months 20 days ago More Impact AG: Subsidiary BG Braingate Technology receives Notice of Allowance from the US Patent and Trademark Office for innovative technology More Impact AG's subsidiary BG Braingate Technology to be granted US patent for innovative extraction process, focusing on cannabinoids and medical devices Innovative Technology US Patent More Impact AG BG Braingate Technology Biological Materials
PRESS RELEASE published on 04/15/2025 at 09:00, 9 months 20 days ago Original-Research: LAIQON AG (von NuWays AG): BUY LAIQON AG, previously NuWays AG, upgraded to BUY with a target price of EUR 7.40 for scaling AuM and improved cost mix. FY'24 review highlights strong sales and EBITDA growth Buy Recommendation LAIQON AG Scaling AuM Cost Mix FY'24 Review
PRESS RELEASE published on 04/15/2025 at 09:00, 9 months 20 days ago FRIWO achieves revised annual targets for 2024 – growth momentum expected from 2025 FRIWO AG achieves revised annual targets for 2024 and anticipates growth momentum from 2025 with improved EBIT and strategic realignment FRIWO AG Annual Targets Strategic Realignment EBIT Improvement Growth Momentum
PRESS RELEASE published on 04/15/2025 at 09:00, 9 months 20 days ago Exasol AG: Supervisory Board resolves early extension of CEO Jörg Tewes‘ contract Exasol AG's Supervisory Board extends CEO Jörg Tewes' contract until 2028 to drive profitable growth and strategic focus. Company specializes in high-performance analytics engine technology Exasol AG Contract Extension Technology Company CEO Jörg Tewes High-performance Analytics
PRESS RELEASE published on 04/15/2025 at 09:00, 9 months 20 days ago Blue Elephant Energy accelerates battery storage strategy with a majority investment in Solar215 Blue Elephant Energy GmbH acquires majority stake in Solar215 GmbH, a Hamburg-based developer specializing in utility-scale BESS, boosting renewable energy storage capabilities Renewable Energy Germany BESS Blue Elephant Energy GmbH Solar215 GmbH
PRESS RELEASE published on 04/15/2025 at 09:00, 9 months 20 days ago Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics Cyprumed and MSD sign a Non-Exclusive License and Option Agreement for the Development of Oral Peptide Therapeutics, potentially unlocking new opportunities in peptide therapeutics Drug Delivery Technology License Agreement Cyprumed Oral Peptide Therapeutics MSD
PRESS RELEASE published on 04/15/2025 at 09:00, 9 months 20 days ago EMERAM achieves success in challenging market environment: four investments and one exit in 2024, double-digit growth expected in 2025 EMERAM Capital Partners achieves success with four investments and one exit in 2024, predicts double-digit growth for 2025 amidst challenging market conditions Double-digit Growth Investments 2025 EMERAM Capital Partners Exit
PRESS RELEASE published on 04/15/2025 at 08:57, 9 months 20 days ago EQS-Adhoc: Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25 Carl Zeiss Meditec AG achieves significant earnings increase in Q2 2024/25, with revenue of EUR 560 million and EBITA of EUR 78 million Revenue Growth Carl Zeiss Meditec AG Earnings Increase EBITA Q2 2024/25
PRESS RELEASE published on 04/15/2025 at 08:32, 9 months 20 days ago Stepstone Salary Report: With these salaries, employees are considered top earners Stepstone Salary Report reveals top earners in Germany with analysis of over 1 million salary data. High salaries in Hamburg, Hesse & south. Insights on top earners without staff responsibility Germany Salariés Stepstone Salary Report Top Earners Staff Responsibility
PRESS RELEASE published on 04/15/2025 at 08:30, 9 months 20 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces transaction in own shares. Numis Securities Limited purchased 13,324 Ordinary Shares at volume weighted average price of 259.5779p on 14-Apr-2025 Shares Molten Ventures Plc Numis Securities Limited GROW Transaction
Published on 02/05/2026 at 09:05, 28 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 7 hours 58 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 9 hours 33 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 11 hours 8 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 09:00, 32 minutes ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 32 minutes ago Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 32 minutes ago Original-Research: Semperit AG Holding (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 33 minutes ago Novem Group S.A.: Q3 2025/26 shows steady Series sales
Published on 02/04/2026 at 18:04, 15 hours 29 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 15 hours 29 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 15 hours 48 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 15 hours 48 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL